Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress

Blood (2023) 142 (25): 2159–2174.

https://doi.org/10.1182/blood.2023020144

Published: 2023

Includes: Supplemental data

Journal Articles

Investigating the Role of the SETDB1 Target TANGO6 (TMCO7) in Leukemia

Jamie Pruitt, Nirmalya Saha, Lauren Lachowski, Andrew G. Muntean

Blood (2023) 142 (Supplement 1): 5695.

https://doi.org/10.1182/blood-2023-178859

Published: 2023

Journal Articles

Investigating the Roles of the Yeats Domain in MLL-ENL Mediated Leukemogenesis

Hsiangyu Hu, BS, Nirmalya Saha, PhD, Yuting Yang, PhD, Sierrah Marie Grigsby, PhD, Rolf Marschalek, PhD, Zaneta Nikolovska-Coleska, PhD, Andrew G. Muntean, PhD

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-138622

Published: 2020

Journal Articles

SETDB1 Mediated H3K9 Methylation Suppresses MLL-Fusion Target Expression and Leukemic Transformation

Andrew G. Muntean, PhD, James Ropa, Nirmalya SAHA, PhD MSc, BSc, Hsiang-Yu Hu, BS, Justin Serio, Lili Zhao, Venkatesha Basrur, Alexei Nesvizhskii, Ivan Maillard, MD PhD

Blood (2019) 134 (Supplement_1): 110.

https://doi.org/10.1182/blood-2019-122610

Published: 2019

Journal Articles

SETDB1 Represses Hox Gene Expression and Suppresses Acute Myeloid Leukemia

James Ropa, BS, Nirmalya SAHA, PhD, Andrew G. Muntean, PhD

Blood (2018) 132 (Supplement 1): 1320.

https://doi.org/10.1182/blood-2018-99-117690

Published: 2018

Journal Articles

The PAF1c Subunit Cdc73 Is Essential for Hematopoiesis and Displays Differential Gene Regulation in MLL-AF9 Driven Leukemia

Nirmalya SAHA, PhD MSc, BSc, James Ropa, BS, Lili Chen, PhD, Hsiang-Yu Hu, BS, Maria Mysliwski, Ann Friedman, BS, Ivan Maillard, MD, Andrew G. Muntean, PhD

Blood (2018) 132 (Supplement 1): 1280.

https://doi.org/10.1182/blood-2018-99-118703

Published: 2018

Journal Articles

The AF9-Binding Domain of DOT1L Is Critical for Its Recruitment By MLL Fusion Proteins in Leukemia and Contributes to Its Functions in Normal Hematopoiesis

Sierrah Marie Grigsby, BS, James Ropa, BS, Justin Serio, BS, Jennifer Chase, PhD, Chenxi Shen, PhD, Andrew G. Muntean, PhD, Ivan Maillard, MD PhD, Zaneta Nikolovska-Coleska, PhD

Blood (2017) 130 (Supplement 1): 3785.

https://doi.org/10.1182/blood.V130.Suppl_1.3785.3785

Published: 2017

Journal Articles

The PAF Complex Regulation of Prmt5 Facilitates Leukemic Progression

Justin Serio, B.S., Wei Chen, Maria Mysliwski, Lili Chen, PhD, James Ropa, B.S., Jingya Wang, PhD, Andrew G. Muntean, PhD

Blood (2016) 128 (22): 3914.

https://doi.org/10.1182/blood.V128.22.3914.3914

Published: 2016

Journal Articles

Differential Regulation of c-Myc/Lin28 Discriminates Subclasses of Rearranged MLL Leukemia

Lili Chen, PhD, Yuqing Sun, Jingya Wang, PhD, Hui Jiang, PhD, Andrew G. Muntean, PhD

Blood (2015) 126 (23): 163.

https://doi.org/10.1182/blood.V126.23.163.163

Published: 2015

Journal Articles

The same site on the integrase-binding domain of lens epithelium–derived growth factor is a therapeutic target for MLL leukemia and HIV

Marcelo J. Murai, Jonathan Pollock, Shihan He, Hongzhi Miao, Trupta Purohit, Adam Yokom, Jay L. Hess, Andrew G. Muntean, Jolanta Grembecka, Tomasz Cierpicki

Blood (2014) 124 (25): 3730–3737.

https://doi.org/10.1182/blood-2014-01-550079

Published: 2014

Includes: Supplemental data

Journal Articles

Characterization of the Molecular Interplay Between HOXA9 and Ogt in Leukemia

Jean-Francois M Rual, PhD, Tao Xu, PhD, Cailin Collins, Honglai Zhang, PhD, Jingya Wang, Rork Kuick, MS, Joel Bronstein, Venkatesha Basrur, PhD, Sung Soo Park, PhD, Kim Ha, Lili Chen, Kojo S.J. Elenitoba-Johnson, MD, Andrew G. Muntean, PhD, Jay L. Hess, MD PhD

Blood (2014) 124 (21): 3533.

https://doi.org/10.1182/blood.V124.21.3533.3533

Published: 2014

Journal Articles

Hyperactive Ptpn11 Mutations Alters Leukemic Stem Cell Frequency through Mcl-1 Overexpression

Lili Chen, PhD, Wei Chen, PhD, Maria Mysliwski, Justin Serio, James Ropa, Fardokht Abulwerdi, Rebecca J. Chan, MD PhD, Jay P. Patel, Martin S. Tallman, MD, Elisabeth M. Paietta, PhD, Ari M Melnick, MD, Ross L. Levine, MD, Omar Abdel-Wahab, MD, Zaneta Nikolovska-Coleska, PhD, Andrew G. Muntean, PhD

Blood (2014) 124 (21): 3565.

https://doi.org/10.1182/blood.V124.21.3565.3565

Published: 2014

Journal Articles

MLL fusion protein–driven AML is selectively inhibited by targeted disruption of the MLL-PAFc interaction

Andrew G. Muntean, Wei Chen, Morgan Jones, Eric M. Granowicz, Ivan Maillard, Jay L. Hess

Blood (2013) 122 (11): 1914–1922.

https://doi.org/10.1182/blood-2013-02-486977

Published: 2013

Includes: Supplemental data

Journal Articles

ECS ASB2 mediates MLL degradation during hematopoietic differentiation

Jingya Wang, Andrew G. Muntean, Jay L. Hess

Blood (2012) 119 (5): 1151–1161.

https://doi.org/10.1182/blood-2011-06-362079

Published: 2012

Includes: Supplemental data

Journal Articles

Targeting Menin-MLL Interaction to Inhibit MLL Fusion Oncoproteins in Leukemia

Jolanta Grembecka, PhD, Shihan He, PhD, Aibin Shi, PhD, Trupta Purohit, Andrew G. Muntean, PhD, Xiaoqin Li, Thomas Hartley, Duxin Sun, PhD, Jay L. Hess, MD, PhD, Tomasz Cierpicki, PhD

Blood (2011) 118 (21): 2497.

https://doi.org/10.1182/blood.V118.21.2497.2497

Published: 2011

Journal Articles

MLL Fusion Protein Driven AML Is Selectively Inhibited by Targeted Disruption of the MLL-PAFc Interaction

Andrew G. Muntean, PhD, Eric M Granowicz, Jay L. Hess, MD, PhD

Blood (2011) 118 (21): 56.

https://doi.org/10.1182/blood.V118.21.56.56

Published: 2011

Journal Articles

A Novel Ubiquitination Pathway Regulates MLL Activity During Hematopoietic Differentiation

Jingya Wang, Ph.D., Andrew G. Muntean, PhD, Jay L. Hess, MD, PhD

Blood (2010) 116 (21): 743.

https://doi.org/10.1182/blood.V116.21.743.743

Published: 2010

Journal Articles

The PAF Complex Synergizes with MLL Fusion Proteins at . Hox Loci to Promote Leukemogenesis.

Andrew G. Muntean, PhD, Jiaying Tan, Venkatesha Basrur, Kojo S.J. Elenitoba-Johnson, Jay Hess

Blood (2009) 114 (22): 1277.

https://doi.org/10.1182/blood.V114.22.1277.1277

Published: 2009

Journal Articles

The PHD fingers of MLL block MLL fusion protein–mediated transformation

Andrew G. Muntean, Diane Giannola, Aaron M. Udager, Jay L. Hess

Blood (2008) 112 (12): 4690–4693.

https://doi.org/10.1182/blood-2008-01-134056

Published: 2008

Includes: Supplemental data

Journal Articles

The MLL PHD Fingers of MLL Block MLL Fusion Protein Mediated Transformation.

Andrew G. Muntean, PhD, Jay L. Hess, MD, PhD

Blood (2007) 110 (11): 976.

https://doi.org/10.1182/blood.V110.11.976.976

Published: 2007

NARROW

Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress

Investigating the Role of the SETDB1 Target TANGO6 (TMCO7) in Leukemia

Investigating the Roles of the Yeats Domain in MLL-ENL Mediated Leukemogenesis

SETDB1 Mediated H3K9 Methylation Suppresses MLL-Fusion Target Expression and Leukemic Transformation

SETDB1 Represses Hox Gene Expression and Suppresses Acute Myeloid Leukemia

The PAF1c Subunit Cdc73 Is Essential for Hematopoiesis and Displays Differential Gene Regulation in MLL-AF9 Driven Leukemia

The AF9-Binding Domain of DOT1L Is Critical for Its Recruitment By MLL Fusion Proteins in Leukemia and Contributes to Its Functions in Normal Hematopoiesis

The PAF Complex Regulation of Prmt5 Facilitates Leukemic Progression

Differential Regulation of c-Myc/Lin28 Discriminates Subclasses of Rearranged MLL Leukemia

The same site on the integrase-binding domain of lens epithelium–derived growth factor is a therapeutic target for MLL leukemia and HIV

Characterization of the Molecular Interplay Between HOXA9 and Ogt in Leukemia

Hyperactive Ptpn11 Mutations Alters Leukemic Stem Cell Frequency through Mcl-1 Overexpression

MLL fusion protein–driven AML is selectively inhibited by targeted disruption of the MLL-PAFc interaction

ECS ASB2 mediates MLL degradation during hematopoietic differentiation

Targeting Menin-MLL Interaction to Inhibit MLL Fusion Oncoproteins in Leukemia

MLL Fusion Protein Driven AML Is Selectively Inhibited by Targeted Disruption of the MLL-PAFc Interaction

A Novel Ubiquitination Pathway Regulates MLL Activity During Hematopoietic Differentiation

The PAF Complex Synergizes with MLL Fusion Proteins at . Hox Loci to Promote Leukemogenesis.

The PHD fingers of MLL block MLL fusion protein–mediated transformation

The MLL PHD Fingers of MLL Block MLL Fusion Protein Mediated Transformation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only